Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Mensah, Adelaide"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Qualitative and quantitative evaluation of cryptolepis-based herbal formulations in Ghana
    (2015-11-02) Mensah, Adelaide
    Cryptolepine is the first and main alkaloid isolated from the West African shrub Cryptolepis Sanguinolenta. Cryptolepine has been extensively studied and scientifically proven to exhibit antimuscarinic, antithrombotic, anti-inflammatory, anti-microbial, hypoglycaemic and antimalarial activities. It is also reported to be cytotoxic, being a DNA intercalator and a topoisomerase II inhibitor. In Ghana, Cryptolepis-based preparations which are mainly aqueous extracts of whole roots of Cryptolepis sanguinolenta are used as antimalarials. Currently, there are a number of branded Cryptolepis Sanguinolenta herbal formulations on the Ghanaian market. The proliferation of these brands calls for pharmacovigilance to ensure that spurious/falsely-labelled/falsified/counterfeit (SFFC) brands are identified to ensure the safety and quality of these formulations and hence improve malaria treatment outcomes.

Kwame Nkrumah University of Science and Technology copyright © 2002-2025